LUNG Pulmonx Corp

Nasdaq pulmonx.com


$ 1.88 $ 0.42 (26.92 %)    

Tuesday, 28-Oct-2025 19:49:07 EDT
QQQ $ 633.55 $ 4.83 (0.77 %)
DIA $ 476.83 $ 1.80 (0.38 %)
SPY $ 687.33 $ 1.82 (0.27 %)
TLT $ 92.10 $ 0.24 (0.26 %)
GLD $ 364.95 $ -2.63 (-0.72 %)
$ 1.98
$ 1.86
$ 1.80 x 200
$ 2.10 x 100
$ 1.86 - $ 2.89
$ 1.47 - $ 9.37
100,342,305
na
80.68M
$ 1.60
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2025 06-30-2025 10-Q
2 05-02-2025 03-31-2025 10-Q
3 02-25-2025 12-31-2024 10-K
4 11-01-2024 09-30-2024 10-Q
5 08-02-2024 06-30-2024 10-Q
6 05-03-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-03-2023 09-30-2023 10-Q
9 08-04-2023 06-30-2023 10-Q
10 05-08-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-10-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-15-2021 12-31-2020 10-K
20 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lake-street-maintains-buy-on-pulmonx-lowers-price-target-to-4

Lake Street analyst Frank Takkinen maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $8 to $4.

 d-boral-capital-maintains-buy-on-pulmonx-lowers-price-target-to-14

D. Boral Capital analyst Jason Kolbert maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $16 to $14.

 pulmonx-preliminary-unaudited-q3-2025-revenue-expected-to-be-215m

Preliminary, Unaudited Third Quarter 2025 RevenueTotal worldwide revenue for the third quarter of 2025 is anticipated to be app...

 d-boral-capital-maintains-buy-on-pulmonx-maintains-16-price-target

D. Boral Capital analyst Jason Kolbert maintains Pulmonx (NASDAQ:LUNG) with a Buy and maintains $16 price target.

 jaeger-and-pulmonx-announce-strategic-partnership-to-integrate-data-qualification-capabilities-into-sentrysuite

Jaeger™ Medical, a global leader in respiratory diagnostic products, is pleased to announce a strategic partnership with Pulmon...

 wells-fargo-maintains-equal-weight-on-pulmonx-lowers-price-target-to-3

Wells Fargo analyst Larry Biegelsen maintains Pulmonx (NASDAQ:LUNG) with a Equal-Weight and lowers the price target from $6 ...

 lake-street-maintains-buy-on-pulmonx-lowers-price-target-to-8

Lake Street analyst Frank Takkinen maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $12 to $8.

 stifel-maintains-buy-on-pulmonx-lowers-price-target-to-5

Stifel analyst Rick Wise maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $16 to $5.

 piper-sandler-downgrades-pulmonx-to-neutral-lowers-price-target-to-25

Piper Sandler analyst Jason Bednar downgrades Pulmonx (NASDAQ:LUNG) from Overweight to Neutral and lowers the price target f...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION